Olema Pharmaceuticals (OLMA) Stock Price, Quote, News & History | Benzinga

SPY769.46−0.47%QQQ719.45−0.79%BTC/USD82,074.85−2.32%DIA525.92−0.34%GLD378.00−0.25%TLT80.48+0.30%

Olema Pharmaceuticals inc (OLMA) Stock Price, Quote, News & History

OLMANASDAQ

Trade with Public

Trade with Public

$7.05

-0.20-2.76%

Last update: Oct 21, 5:15 PM

$7.10

-0.15-2.07%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$7.05

Volume / Avg.

0 / 1.09M

Day Range

- - -

52 Wk Range

6.48 - 36.26

Market Cap

$621.23M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

20.4%

Days to Cover

10.19

Recent Olema Pharmaceuticals, Inc. News

Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

U.S. stock futures fell, with Nasdaq 100 futures down 500 points. Corning dropped 8% after a $2B offering; several other stocks also slid premarket.

Avi Kapoor

Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premarket gainers, while Picocela fell.

Avi Kapoor

Olema Pharmaceuticals Stock Falls as Pivotal Breast Cancer Data Pushed Into 2027

Olema Pharmaceuticals shares fall after completing OPERA-01 Phase 3 enrollment, with top-line data now expected in Q1 2027.

Vandana Singh

OppFi Posts Downbeat Q2 Earnings, Joins Upwork, Rocket Lab And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures mostly lower. OppFi (OPFI) shares fall after missing Q2 earnings and cutting FY26 guidance. Other stocks also down in pre-market.

Avi Kapoor

Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday

Top analysts changed outlook on top names. Mizuho, Needham, Rothschild & Co, HC Wainwright & Co, Stifel, BTIG, Goldman Sachs made changes.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-164.74M

Investing Cash Flow (TTM)

-99.54M

Financing Cash Flow (TTM)

260.40M

Free Cash Flow (TTM)

-164.96M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-3.87M

Analyst Trends and Forecast

1

May

3

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$158.57M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.43

Earnings Yield % (TTM)

-30.11%

Earnings Yield % (FWD)

-39.49%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.92

Company Debt

Total Debt

$3.00M

LT Debt

$3.00M

LT Debt Issuance (TTM)

$0

LT Debt Repayment (TTM)

-

Total Cash

$48.60M

Debt to Equity

0.01

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

-